Next Article in Journal
Rickettsia Vaccine Candidate pVAX1-OmpB24 Stimulates TCD4+INF-γ+ and TCD8+INF-γ+ Lymphocytes in Autologous Co-Culture of Human Cells
Previous Article in Journal
Rural Americans’ COVID-19 Vaccine Perceptions and Willingness to Vaccinate against COVID-19 with Their Community Pharmacists: An Exploratory Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499

by
Mariapia Guerrieri
1,†,
Beatrice Francavilla
1,*,†,
Denise Fiorelli
2,
Marzia Nuccetelli
2,
Francesco Maria Passali
1,
Luca Coppeta
3,
Giuseppina Somma
3,
Sergio Bernardini
2,4,
Andrea Magrini
3 and
Stefano Di Girolamo
1
1
Department of Otorhinolaryngology, University of Rome “Tor Vergata”, 00100 Rome, Italy
2
Department of Experimental Medicine, University of Rome “Tor Vergata”, 00100 Rome, Italy
3
Department of Occupational Medicine, University of Rome “Tor Vergata”, 00100 Rome, Italy
4
Department of Laboratory Medicine, Tor Vergata University Hospital, 00100 Rome, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Vaccines 2023, 11(1), 172; https://doi.org/10.3390/vaccines11010172
Submission received: 12 December 2022 / Accepted: 3 January 2023 / Published: 13 January 2023

Error in Figure

The authors wish to make the following corrections to this paper [1]:
In the original publication, there was a mistake in Figure 2 as published. The same image was mistakenly selected for Figure 2 and Figure 3 during proofreading. The corrected Figure 2 appears below.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Guerrieri, M.; Francavilla, B.; Fiorelli, D.; Nuccetelli, M.; Passali, F.M.; Coppeta, L.; Somma, G.; Bernardini, S.; Magrini, A.; Di Girolamo, S. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499. [Google Scholar] [CrossRef] [PubMed]
Figure 2. Anti-SARS-CoV-2 IgA-S1 and anti-SARS-CoV-2 IgG-RBD in saliva samples. (a) Saliva sample median levels of anti-SARS-CoV-2 IgA-S1 in the three study groups, expressed as COI (Cut off index). (b) Saliva sample median levels of anti-SARS-CoV-2 IgG-RBD in the three study groups, expressed as Binding Antibody Units (BAU/mL). In the COVID-19 group, the red rhombuses represent the hospitalized subjects. Statistical analysis and construction of figures were performed with GraphPad Prism 8 Software (GraphPad Software, San Diego, CA, USA). The D’Agostino and Pearson test, the Shapiro-Wilk normality test, and the Kolmogorov–Smirnov test were used to evaluate non-Gaussian distributions in all of the study populations. The continuous data were displayed as median and range. Non-parametric results were analysed with the Mann–Whitney test. For all results, p < 0.05 was considered statistically significant.
Figure 2. Anti-SARS-CoV-2 IgA-S1 and anti-SARS-CoV-2 IgG-RBD in saliva samples. (a) Saliva sample median levels of anti-SARS-CoV-2 IgA-S1 in the three study groups, expressed as COI (Cut off index). (b) Saliva sample median levels of anti-SARS-CoV-2 IgG-RBD in the three study groups, expressed as Binding Antibody Units (BAU/mL). In the COVID-19 group, the red rhombuses represent the hospitalized subjects. Statistical analysis and construction of figures were performed with GraphPad Prism 8 Software (GraphPad Software, San Diego, CA, USA). The D’Agostino and Pearson test, the Shapiro-Wilk normality test, and the Kolmogorov–Smirnov test were used to evaluate non-Gaussian distributions in all of the study populations. The continuous data were displayed as median and range. Non-parametric results were analysed with the Mann–Whitney test. For all results, p < 0.05 was considered statistically significant.
Vaccines 11 00172 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Guerrieri, M.; Francavilla, B.; Fiorelli, D.; Nuccetelli, M.; Passali, F.M.; Coppeta, L.; Somma, G.; Bernardini, S.; Magrini, A.; Di Girolamo, S. Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499. Vaccines 2023, 11, 172. https://doi.org/10.3390/vaccines11010172

AMA Style

Guerrieri M, Francavilla B, Fiorelli D, Nuccetelli M, Passali FM, Coppeta L, Somma G, Bernardini S, Magrini A, Di Girolamo S. Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499. Vaccines. 2023; 11(1):172. https://doi.org/10.3390/vaccines11010172

Chicago/Turabian Style

Guerrieri, Mariapia, Beatrice Francavilla, Denise Fiorelli, Marzia Nuccetelli, Francesco Maria Passali, Luca Coppeta, Giuseppina Somma, Sergio Bernardini, Andrea Magrini, and Stefano Di Girolamo. 2023. "Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499" Vaccines 11, no. 1: 172. https://doi.org/10.3390/vaccines11010172

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop